Long-Term Experimental Hyperglycemia Does Not Impair Macrovascular Endothelial Barrier Integrity and Function in...

Area of Science:

• Endocrinology
• Vascular Biology
• Cell Biology

Background:

• Hyperglycemia is a key feature of type 2 diabetes, linked to vascular endothelial dysfunction and cardiovascular issues.
• In vitro studies suggest hyperglycemia induces endothelial apoptosis, a significant factor in vascular injury.
• However, in vivo evidence of endothelial apoptosis in type 2 diabetes appears late.

Purpose of the Study:

• To investigate the long-term effects of high glucose on human umbilical vein endothelial cells (HUVEC) in vitro.
• To assess whether prolonged exposure to high glucose impacts endothelial cell integrity, apoptosis, and barrier function.

Main Methods:

• Cultured HUVECs in high glucose (30 mM) for up to 4 weeks.
• Monitored HUVEC monolayer morphology, reactive oxygen species (ROS) levels, and nitric oxide (NO) production.
• Assessed apoptosis markers, barrier responses, and key regulators of cytoskeletal contractility.

Main Results:

• High glucose did not significantly alter HUVEC monolayer morphology, ROS levels, or NO production.
• Apoptosis markers showed only minor changes, and barrier responses were similar to cells in physiological glucose (5 mM).
• No differences were observed in histamine-induced intracellular Ca2+ responses or myosin regulatory light chain phosphorylation.

Conclusions:

• Human umbilical vein endothelial cells demonstrate tolerance to prolonged high glucose exposure in vitro.
• These findings challenge the notion that hyperglycemia directly causes early endothelial apoptosis.
• Further research is needed to understand the mechanisms of vascular damage in advanced type 2 diabetes.